Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Use of a web-based app to improve postoperative outcomes for patients receiving gynecological oncology care: A randomized controlled feasibility trial.

Graetz I, Anderson JN, McKillop CN, Stepanski EJ, Paladino AJ, Tillmanns TD.

Gynecol Oncol. 2018 Aug;150(2):311-317. doi: 10.1016/j.ygyno.2018.06.007. Epub 2018 Jun 11.

PMID:
29903391
2.

Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial.

Graetz I, McKillop CN, Stepanski E, Vidal GA, Anderson JN, Schwartzberg LS.

J Cancer Surviv. 2018 Aug;12(4):431-440. doi: 10.1007/s11764-018-0682-z. Epub 2018 Feb 28.

3.

Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma.

Samuels BL, Chawla SP, Somaiah N, Staddon AP, Skubitz KM, Milhem MM, Kaiser PE, Portnoy DC, Priebat DA, Walker MS, Stepanski EJ.

Cancer. 2017 Dec 1;123(23):4640-4647. doi: 10.1002/cncr.30926. Epub 2017 Aug 18.

4.

mHealth: Mobile Technologies to Virtually Bring the Patient Into an Oncology Practice.

Pennell NA, Dicker AP, Tran C, Jim HSL, Schwartz DL, Stepanski EJ.

Am Soc Clin Oncol Educ Book. 2017;37:144-154. doi: 10.14694/EDBK_176093.

5.

Analysis of the psychological impact of cancer-related symptoms on patients with non-small cell lung cancer.

Walker MS, Pohl GM, Houts AC, Peltz G, Miller PJE, Schwartzberg LS, Stepanski EJ, Marciniak M.

Psychooncology. 2017 Jun;26(6):755-762. doi: 10.1002/pon.4071. Epub 2016 Jan 20.

PMID:
26790987
6.

Use of "Real-World" data to describe adverse events during the treatment of metastatic renal cell carcinoma in routine clinical practice.

Hirsch BR, Harrison MR, George DJ, Walker MS, Chen C, Korytowsky B, Stepanski E, Abernethy AP.

Med Oncol. 2014 Sep;31(9):156. doi: 10.1007/s12032-014-0156-8. Epub 2014 Aug 14.

PMID:
25115744
7.

Treatment patterns and outcomes among patients with metastatic melanoma treated in community practice.

Walker MS, Reyes C, Kerr J, Satram-Hoang S, Stepanski EJ.

Int J Dermatol. 2014 Nov;53(11):e499-506. doi: 10.1111/ijd.12427. Epub 2014 Mar 6.

PMID:
24602078
8.

Real-world outcomes in metastatic renal cell carcinoma: insights from a Joint Community-Academic Registry.

Harrison MR, Hirsch BR, George DJ, Walker MS, Chen C, Korytowsky B, Stepanski E, Abernethy AP.

J Oncol Pract. 2014 Mar;10(2):e63-72. doi: 10.1200/JOP.2013.001180. Epub 2013 Nov 26.

PMID:
24281152
9.

Phase II trial of fulvestrant with metronomic capecitabine for postmenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer.

Schwartzberg LS, Wang G, Somer BG, Blakely LJ, Wheeler BM, Walker MS, Stepanski EJ, Houts AC.

Clin Breast Cancer. 2014 Feb;14(1):13-9. doi: 10.1016/j.clbc.2013.09.003. Epub 2013 Sep 27.

PMID:
24268206
10.

Willingness to pay to prevent chemotherapy induced nausea and vomiting among patients with breast, lung, or colorectal cancer.

Miller PJ, Balu S, Buchner D, Walker MS, Stepanski EJ, Schwartzberg LS.

J Med Econ. 2013 Oct;16(10):1179-89. doi: 10.3111/13696998.2013.832257. Epub 2013 Sep 5.

PMID:
23919632
11.

Prospective observational comparison of clinical outcomes between african-american and caucasian patients receiving second-line treatment with pemetrexed for advanced non-small-cell lung cancer.

Pennella E, Obasaju CK, Pohl G, Peltz G, Girvan AC, Winfree KB, Martinez B, Marciniak M, Walker MS, Stepanski E, Schwartzberg LS, Adjei A.

Clin Lung Cancer. 2013 Nov;14(6):726-35. doi: 10.1016/j.cllc.2013.06.011. Epub 2013 Jul 31.

PMID:
23910068
12.

"Real world" treatment of metastatic renal cell carcinoma in a joint community-academic cohort: progression-free survival over three lines of therapy.

Harrison MR, George DJ, Walker MS, Chen C, Korytowsky B, Kirkendall DT, Stepanski EJ, Abernethy AP.

Clin Genitourin Cancer. 2013 Dec;11(4):441-50. doi: 10.1016/j.clgc.2013.05.002. Epub 2013 Jul 12.

PMID:
23856102
13.

Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumab.

Schwartzberg LS, Tauer KW, Hermann RC, Makari-Judson G, Isaacs C, Beck JT, Kaklamani V, Stepanski EJ, Rugo HS, Wang W, Bell-McGuinn K, Kirshner JJ, Eisenberg P, Emanuelson R, Keaton M, Levine E, Medgyesy DC, Qamar R, Starr A, Ro SK, Lokker NA, Hudis CA.

Clin Cancer Res. 2013 May 15;19(10):2745-54. doi: 10.1158/1078-0432.CCR-12-3177. Epub 2013 Feb 26.

14.

The discrepancy between subjective and objective measures of sleep in older adults receiving CBT for comorbid insomnia.

Lund HG, Rybarczyk BD, Perrin PB, Leszczyszyn D, Stepanski E.

J Clin Psychol. 2013 Oct;69(10):1108-20. doi: 10.1002/jclp.21938. Epub 2012 Dec 20.

PMID:
23280680
15.

Relationship between incidence of fracture and health-related quality-of-life in metastatic breast cancer patients with bone metastases.

Walker MS, Miller PJ, Namjoshi M, Houts AC, Stepanski EJ, Schwartzberg LS.

J Med Econ. 2013;16(1):179-89. doi: 10.3111/13696998.2012.737883. Epub 2012 Oct 23.

PMID:
23043593
16.

Phase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinoma.

Tillmanns TD, Lowe MP, Walker MS, Stepanski EJ, Schwartzberg LS.

Gynecol Oncol. 2013 Feb;128(2):221-8. doi: 10.1016/j.ygyno.2012.08.039. Epub 2012 Sep 5.

PMID:
22960352
17.

Symptom burden & quality of life among patients receiving second-line treatment of metastatic colorectal cancer.

Walker MS, Pharm EY, Kerr J, Yim YM, Stepanski EJ, Schwartzberg LS.

BMC Res Notes. 2012 Jun 20;5:314. doi: 10.1186/1756-0500-5-314.

18.

The association of rash severity with overall survival: findings from patients receiving erlotinib for pancreatic cancer in the community setting.

Stepanski EJ, Reyes C, Walker MS, Satram-Hoang S, Leon L, Wojtowicz-Praga S, Miller PJ, Houts AC, Schwartzberg LS.

Pancreas. 2013 Jan;42(1):32-6. doi: 10.1097/MPA.0b013e318254f19a.

PMID:
22699203
19.

Hematologic outcomes and blood utilization in cancer patients with chemotherapy-induced anemia (CIA) pre- and post-national coverage determination (NCD): results from a multicenter chart review.

Henry DH, Langer CJ, McKenzie RS, Piech CT, Senbetta M, Schulman KL, Stepanski EJ.

Support Care Cancer. 2012 Sep;20(9):2089-96. doi: 10.1007/s00520-011-1318-2. Epub 2011 Dec 11.

PMID:
22160485
20.

Testing two types of self-help CBT-I for insomnia in older adults with arthritis or coronary artery disease.

Rybarczyk B, Mack L, Harris JH, Stepanski E.

Rehabil Psychol. 2011 Nov;56(4):257-66. doi: 10.1037/a0025577.

PMID:
22121936
21.

Retrospective study of the effect of disease progression on patient reported outcomes in HER-2 negative metastatic breast cancer patients.

Walker MS, Hasan M, Yim YM, Yu E, Stepanski EJ, Schwartzberg LS.

Health Qual Life Outcomes. 2011 Jun 20;9:46. doi: 10.1186/1477-7525-9-46.

22.

Testing the reliability and validity of DSM-IV-TR and ICSD-2 insomnia diagnoses. Results of a multitrait-multimethod analysis.

Edinger JD, Wyatt JK, Stepanski EJ, Olsen MK, Stechuchak KM, Carney CE, Chiang A, Crisostomo MI, Lineberger MD, Means MK, Radtke RA, Wohlgemuth WK, Krystal AD.

Arch Gen Psychiatry. 2011 Oct;68(10):992-1002. doi: 10.1001/archgenpsychiatry.2011.64. Epub 2011 Jun 6.

PMID:
21646568
23.

Symptom Burden and Quality of Life in Patients with Follicular Lymphoma undergoing Maintenance Treatment with Rituximab Compared with Observation.

Walker MS, Stepanski EJ, Reyes C, Satram-Hoang S, Houts AC, Schwartzberg LS.

Ther Adv Hematol. 2011 Jun;2(3):129-39. doi: 10.1177/2040620711407675.

24.

Examining maladaptive beliefs about sleep across insomnia patient groups.

Carney CE, Edinger JD, Morin CM, Manber R, Rybarczyk B, Stepanski EJ, Wright H, Lack L.

J Psychosom Res. 2010 Jan;68(1):57-65. doi: 10.1016/j.jpsychores.2009.08.007.

25.

The relation of trouble sleeping, depressed mood, pain, and fatigue in patients with cancer.

Stepanski EJ, Walker MS, Schwartzberg LS, Blakely LJ, Ong JC, Houts AC.

J Clin Sleep Med. 2009 Apr 15;5(2):132-6.

26.
27.

Second- and third-line treatment of patients with non-small-cell lung cancer with erlotinib in the community setting: retrospective study of patient healthcare utilization and symptom burden.

Stepanski EJ, Houts AC, Schwartzberg LS, Walker MS, Reyes CM, Blakely J.

Clin Lung Cancer. 2009 Nov;10(6):426-32. doi: 10.3816/CLC.2009.n.080.

PMID:
19900861
28.

A retrospective study of quality of life in a community sample of patients with early stage breast cancer.

Walker MS, Schwartzberg LS, Stepanski EJ, Fortner BV.

Breast Cancer Res Treat. 2009 May;115(2):415-22. doi: 10.1007/s10549-009-0387-0. Epub 2009 Apr 17.

PMID:
19373552
29.

Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer.

Schwartzberg LS, Cobb P, Senecal F, Henry D, Kulig K, Walker MS, Houts AC, Stepanski EJ.

Breast. 2009 Apr;18(2):78-83. doi: 10.1016/j.breast.2009.01.002. Epub 2009 Apr 1.

PMID:
19342237
30.

Pain coping strategies for tension-type headache: possible implications for insomnia?

Ong JC, Stepanski EJ, Gramling SE.

J Clin Sleep Med. 2009 Feb 15;5(1):52-6.

31.

Patient and practice impact of capecitabine compared to taxanes in first-/second-line chemotherapy for metastatic breast cancer.

Schwartzberg LS, Cobb P, Walker MS, Stepanski EJ, Houts AC.

Support Care Cancer. 2009 Aug;17(8):1081-8. doi: 10.1007/s00520-008-0558-2. Epub 2009 Jan 13.

PMID:
19148686
32.

Symptom Burden for Patients with Metastatic Colorectal Cancer Treated with First-Line FOLFOX or FOLFIRI with and Without Bevacizumab in the Community Setting.

Fortner BV, Schwartzberg LS, Stepanski EJ, Houts AC.

Support Cancer Ther. 2007 Sep 1;4(4):233-40. doi: 10.3816/SCT.2007.n.020.

PMID:
18632522
33.

Implications of IV monoclonal antibody infusion reaction for the patient, caregiver, and practice: results of a multicenter study.

Schwartzberg LS, Stepanski EJ, Walker MS, Mathias S, Houts AC, Fortner BV.

Support Care Cancer. 2009 Jan;17(1):91-8. doi: 10.1007/s00520-008-0474-5. Epub 2008 Jul 1.

PMID:
18592276
34.

Impact of sleep disturbances in inflammatory bowel disease.

Ranjbaran Z, Keefer L, Farhadi A, Stepanski E, Sedghi S, Keshavarzian A.

J Gastroenterol Hepatol. 2007 Nov;22(11):1748-53.

PMID:
17914945
35.

Retrospective chart review of severe infusion reactions with rituximab, cetuximab, and bevacizumab in community oncology practices: assessment of clinical consequences.

Schwartzberg LS, Stepanski EJ, Fortner BV, Houts AC.

Support Care Cancer. 2008 Apr;16(4):393-8. Epub 2007 Oct 2.

PMID:
17909865
36.

The need for a standardized CPAP titration protocol and follow-up procedures.

Stepanski EJ.

J Clin Sleep Med. 2005 Jul 15;1(3):311. No abstract available.

PMID:
17566195
37.

Hypnotics should not be considered for the initial treatment of chronic insomnia. Con.

Stepanski EJ.

J Clin Sleep Med. 2005 Apr 15;1(2):125-8. Erratum in: J Clin Sleep Med. 2005 Jul 15;1(3):235.

PMID:
17561624
38.

Improving the utility of interpreting sleep fragmentation.

Stepanski EJ.

J Clin Sleep Med. 2007 Apr 15;3(3):275-6. No abstract available.

39.

Sleep fragmentation, sleep deprivation, or both.

Stepanski EJ.

J Clin Sleep Med. 2006 Oct 15;2(4):479; author reply 480. No abstract available.

PMID:
17557481
40.

An initial report of sleep disturbance in inactive inflammatory bowel disease.

Keefer L, Stepanski EJ, Ranjbaran Z, Benson LM, Keshavarzian A.

J Clin Sleep Med. 2006 Oct 15;2(4):409-16.

PMID:
17557469
41.

Impact of adherence with positive airway pressure therapy on hypercapnia in obstructive sleep apnea.

Mokhlesi B, Tulaimat A, Evans AT, Wang Y, Itani AA, Hassaballa HA, Herdegen JJ, Stepanski EJ.

J Clin Sleep Med. 2006 Jan 15;2(1):57-62.

42.

The scoring of cardiac events during sleep.

Caples SM, Rosen CL, Shen WK, Gami AS, Cotts W, Adams M, Dorostkar P, Shivkumar K, Somers VK, Morgenthaler TI, Stepanski EJ, Iber C.

J Clin Sleep Med. 2007 Mar 15;3(2):147-54. Review.

PMID:
17557424
43.

The scoring of arousal in sleep: reliability, validity, and alternatives.

Bonnet MH, Doghramji K, Roehrs T, Stepanski EJ, Sheldon SH, Walters AS, Wise M, Chesson AL Jr.

J Clin Sleep Med. 2007 Mar 15;3(2):133-45. Review.

PMID:
17557423
44.

Adherence, reports of benefits, and depression among patients treated with continuous positive airway pressure.

Wells RD, Freedland KE, Carney RM, Duntley SP, Stepanski EJ.

Psychosom Med. 2007 Jun;69(5):449-54. Epub 2007 Jun 7.

PMID:
17556641
45.

The relevance of sleep abnormalities to chronic inflammatory conditions.

Ranjbaran Z, Keefer L, Stepanski E, Farhadi A, Keshavarzian A.

Inflamm Res. 2007 Feb;56(2):51-7. Review.

PMID:
17431741
46.
47.

Recent developments in the classification, evaluation, and treatment of insomnia.

Summers MO, Crisostomo MI, Stepanski EJ.

Chest. 2006 Jul;130(1):276-86. Review.

PMID:
16840413
48.

The case for trait determinants of arousal and sleepiness.

Stepanski EJ, Burgess HJ.

Sleep. 2005 Jun;28(6):664-5. No abstract available.

PMID:
16477951
49.

A placebo-controlled test of cognitive-behavioral therapy for comorbid insomnia in older adults.

Rybarczyk B, Stepanski E, Fogg L, Lopez M, Barry P, Davis A.

J Consult Clin Psychol. 2005 Dec;73(6):1164-74.

PMID:
16392989
50.

Emerging research on the treatment and etiology of secondary or comorbid insomnia.

Stepanski EJ, Rybarczyk B.

Sleep Med Rev. 2006 Feb;10(1):7-18. Epub 2005 Dec 20. Review.

PMID:
16376125

Supplemental Content

Loading ...
Support Center